CO-DIAGNOSTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.11 USD | -2.63% |
|
-3.48% | -16.54% |
| 12/04 | Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event | CI |
| 04/04 | Co-Diagnostics, Inc. Appoints Executive Appointments | CI |
Chart calendar Co-Diagnostics, Inc.
2aeec6d0adf7252ca17c908e005b0.PL25dKtiUwkAbz368ilWFOXqqCwzRvXv1JeI8GBYFGA.TPXeQM0REHw3KW6RgEwhJ7K6z293dMGOmNLGwCgAUCJFhPQh4gYyYmkueA~1c02561e091c576ae09e3b8d4ab54960
Upcoming events on Co-Diagnostics, Inc.
Past events on Co-Diagnostics, Inc.
| 27/04/2024 | Asia Pacific Region Conference |
| 21/03/2024 02:30 pm | Infectious Disease Diagnostics and Molecular Diagnostics Conference |
| 15/03/2024 02:00 am | Q4 2023 Earnings Call |
| 15/03/2024 01:31 am | Q4 2023 Earnings Release |
| 13/02/2024 | ReSViNET Conference |
| 07/02/2024 | BIOUTAH Life Science Conference |
| 05/02/2024 | Informa Markets Medlab Middle East Meeting |
| 29/01/2024 | ICMR National Institute for Research Advanced TB Diagnostics Conference |
| 30/11/2023 10:40 pm | Piper Sandler Healthcare Conference |
| 28/11/2023 | NIH Research and Innovation Translation Partnerships in Point-of-Care Technologies Conference |
| 17/11/2023 10:00 pm | Association for Molecular Pathology Meeting |
| 16/11/2023 03:35 pm | MEDICA Meeting |
| 15/11/2023 | World Lung Health Conference |
| 10/11/2023 03:00 am | Q3 2023 Earnings Call |
| 10/11/2023 02:31 am | Q3 2023 Earnings Release |
| 09/11/2023 | Utah Life Sciences Summit |
| 23/10/2023 | Caribbean Association of Medical Technologies Scientific Symposium |
| 21/09/2023 07:00 pm | Gilmartin Group Emerging Growth Company Showcase |
| 13/09/2023 12:00 am | H.C. Wainwright Global Investment Conference |
| 30/08/2023 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,21 0,21 4.35% | 74,6 72,4 3.02% | 97,9 98,4 -0.54% | 34,2 38,3 -10.7% | 6,81 6,88 -1.02% | 5,83 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 41,8 40,7 2.78% | 52,1 40,5 28.62% | -3,10 1,50 -306.47% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,89 -5,94 0.74% | 41,7 38,4 8.45% | 46,1 40,2 14.48% | -27,0 -6,95 -288.45% | -42,7 -39,2 -8.93% | -42,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,20 -6,12 -1.2% | 42,6 39,8 6.84% | 45,6 40,0 14.19% | -18,8 0,21 -9096.29% | -38,1 -35,4 -7.56% | -41,5 |
|
Net income Million USD | Released Forecast Spread | -6,20 -6,12 -1.2% | 42,5 42,8 -0.65% | 36,7 32,8 11.65% | -14,2 3,06 -565.23% | -35,3 -26,8 -31.94% | -31,2 |
|
EPS USD | Released Forecast Spread | -0,36 -0,36 -0.93% | 1,52 1,56 -2.36% | 1,23 1,10 12.07% | -0,45 0,09 -600% | -1,20 -0,90 -33.33% | -0,99 |
| Announcement Date | 30/03/20 | 25/03/21 | 24/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,4 20,9 -2.54% | 22,7 21,2 7.24% | 5,02 19,0 -73.56% | 5,09 7,48 -31.92% | 1,40 5,50 -74.52% | 0,60 1,10 -45.28% | 0,20 0,50 -60.44% | 2,46 0,20 1128.55% | 3,56 3,63 -1.93% | 3,05 | 2,55 | 0,08 | 0,15 |
|
EBIT Million USD | Released Forecast Spread | 10,3 4,48 130.06% | 9,82 7,14 37.52% | -4,15 4,19 -198.93% | -6,54 -1,98 -229.41% | -26,1 -6,09 -329.1% | -9,95 -9,34 -6.54% | -12,0 -9,90 -21.16% | -8,94 -12,0 25.22% | -11,8 -8,33 -42.04% | -8,90 | -9,40 | -11,9 | -11,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 10,2 4,57 123.92% | 13,1 7,19 82.32% | -3,43 4,23 -180.96% | -3,48 -1,62 -114.77% | -25,0 -5,99 -318.28% | -8,02 -9,24 13.26% | -11,2 -9,80 -13.85% | -8,10 -11,8 31.22% | -10,8 -8,17 -32.79% | -8,76 | -9,28 | -11,8 | -11,7 |
|
Net income Million USD | Released Forecast Spread | 7,50 3,67 104.06% | 11,7 5,73 104.42% | -2,69 3,37 -179.68% | -1,36 -1,26 -8.12% | -21,9 -4,61 -375.53% | -5,76 -7,10 18.93% | -8,92 -7,35 -21.34% | -5,98 -8,83 32.24% | -14,7 -6,12 -139.65% | -6,57 | -6,96 | -8,83 | -8,79 |
|
EPS USD | Released Forecast Spread | 0,25 0,12 108.33% | 0,34 0,17 96.16% | -0,08 0,10 -182.76% | -0,04 -0,03 -20.01% | -0,68 -0,15 -353.33% | -0,20 -0,23 11.11% | -0,31 -0,24 -29.17% | -0,20 -0,29 31.03% | -0,50 -0,20 -150% | -0,21 | -0,22 | -0,28 | -0,28 |
| Announcement Date | 24/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 16/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 14/03/24 | - | - | - | - |
More events
Past sector events for Co-Diagnostics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CODX Stock
- Calendar Co-Diagnostics, Inc.
